
What’s behind Switzerland’s push for drug-pricing secrecy?
More therapies are coming on the market with price tags over CHF100,000 and limited clinical evidence, creating new challenges for health insurers. Keystone-SDA Listen to the article Listening the article Toggle language selector Select your language Close …